Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beat Steiner

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Cureus|May 19, 2021
Medical School to Residency: How Can We Trust the Process?Gary L Beck Dallaghan, Irene Alexandraki, Jennifer Christner, et al.
Annals of Family Medicine|January 19, 2011
Family medicine clerkship curriculum--next steps, Heidi Chumley, Patricia Carney, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2011
The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammationLuca Piali, Sylvie Froidevaux, Patrick Hess, et al.
Plos One|November 9, 2013
Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetesSylvaine You, Luca Piali, Chantal Kuhn, et al.
The American Journal of Medicine|September 8, 2019
Aligning Medical Student Curriculum with Practice Quality Goals: Impacts on Quality Metrics and Practice Capacity for StudentsAmy W Shaheen, Kelly Bossenbroek Fedoriw, Susanna Khachaturyan, et al.
Journal of Healthcare Management / American College of Healthcare Executives|May 3, 2014
Costs and benefits of transforming primary care practices: a qualitative study of North Carolina's Improving Performance in PracticeKristin L Reiter, Jacqueline R Halladay, C Madeline Mitchell, et al.
The Journal of Biological Chemistry|April 17, 2013
Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signalingKatrin Sobel, Katalin Menyhart, Nina Killer, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 7, 2019
Students Adding Value: Improving Patient Care Measures While Learning Valuable Population Health SkillsAmy W Shaheen, Kelly Bossenbroek Fedoriw, Susanna Khachaturyan, et al.
Molecular Pharmacology|December 6, 2017
S1P<sub>1</sub> Modulator-Induced G <i></i><sub>i</sub> Signaling and <i>β</i>-Arrestin Recruitment Are Both Necessary to Induce Rapid and Efficient Reduction of Blood Lymphocyte Count In VivoMagdalena Birker-Robaczewska, Martin Bolli, Markus Rey, et al.
Journal of Medicinal Chemistry|November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than ClopidogrelEva Caroff, Francis Hubler, Emmanuel Meyer, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Cureus|May 19, 2021
Medical School to Residency: How Can We Trust the Process?Gary L Beck Dallaghan, Irene Alexandraki, Jennifer Christner, et al.
Annals of Family Medicine|January 19, 2011
Family medicine clerkship curriculum--next steps, Heidi Chumley, Patricia Carney, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2011
The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammationLuca Piali, Sylvie Froidevaux, Patrick Hess, et al.
Plos One|November 9, 2013
Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetesSylvaine You, Luca Piali, Chantal Kuhn, et al.
The American Journal of Medicine|September 8, 2019
Aligning Medical Student Curriculum with Practice Quality Goals: Impacts on Quality Metrics and Practice Capacity for StudentsAmy W Shaheen, Kelly Bossenbroek Fedoriw, Susanna Khachaturyan, et al.
Journal of Healthcare Management / American College of Healthcare Executives|May 3, 2014
Costs and benefits of transforming primary care practices: a qualitative study of North Carolina's Improving Performance in PracticeKristin L Reiter, Jacqueline R Halladay, C Madeline Mitchell, et al.
The Journal of Biological Chemistry|April 17, 2013
Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signalingKatrin Sobel, Katalin Menyhart, Nina Killer, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 7, 2019
Students Adding Value: Improving Patient Care Measures While Learning Valuable Population Health SkillsAmy W Shaheen, Kelly Bossenbroek Fedoriw, Susanna Khachaturyan, et al.
Molecular Pharmacology|December 6, 2017
S1P<sub>1</sub> Modulator-Induced G <i></i><sub>i</sub> Signaling and <i>β</i>-Arrestin Recruitment Are Both Necessary to Induce Rapid and Efficient Reduction of Blood Lymphocyte Count In VivoMagdalena Birker-Robaczewska, Martin Bolli, Markus Rey, et al.
Journal of Medicinal Chemistry|November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than ClopidogrelEva Caroff, Francis Hubler, Emmanuel Meyer, et al.
Pageof 6